Loading...
Appropriateness of granulocyte colony-stimulating factor use in patients receiving chemotherapy by febrile neutropenia risk level
OBJECTIVE: Inappropriate granulocyte colony-stimulating factor use with myelosuppressive chemotherapy has been reported. Using the Oncology Services Comprehensive Electronic Records electronic medical record database, prophylactic granulocyte colony-stimulating factor (pegfilgrastim/filgrastim) use...
Na minha lista:
| Udgivet i: | J Oncol Pharm Pract |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6716357/ https://ncbi.nlm.nih.gov/pubmed/30200842 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1078155218799859 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|